What happens if you inject Wegovy in the wrong spot?

Which sites are licensed, and why does 'wrong spot' mean different things to different people?

The licensed injection sites for Wegovy are three: the abdomen (stomach area, avoiding a two-inch radius around the navel), the front of the thigh, and the outer upper arm. When people ask what happens if they inject in the wrong spot, they usually mean one of four separate scenarios: the wrong anatomical zone entirely, the right zone but the wrong precise point within it, the same spot used too frequently, or the needle depth being off because of angle or pinching technique.

Each scenario has a different consequence. Injecting outside the three approved zones, for instance into a muscle rather than the subcutaneous fat layer beneath the skin, may mean the medicine absorbs faster or less predictably than intended, sometimes causing more intense side effects early on. Injecting into the right general area but clipping a small blood vessel can produce localised bruising that looks dramatic but is almost always harmless. Repeated use of the same point is probably the most common practical error and creates the most clinically meaningful problem over time.

The NHS semaglutide guidance recommends rotating sites systematically. The reasoning is straightforward: fatty tissue that receives injections repeatedly can develop lipohypertrophy, a build-up of scar-like tissue that absorbs medicines unpredictably. Our guide to the best spot to inject Wegovy goes into rotation patterns in more detail.

What actually happens to your body when an injection lands off-target?

If the needle tip ends up in the wrong tissue layer, the drug's absorption timeline changes. Wegovy is designed for subcutaneous delivery, meaning the layer of fat just under the skin. Hit muscle instead and you may notice slightly sharper discomfort at the moment of injection, and the drug may peak in your bloodstream earlier than intended. For most people this is imperceptible, but nausea and other gastrointestinal effects can feel more pronounced when blood levels rise steeply.

Hitting scar tissue is a more common issue, particularly in the abdomen if someone has had previous surgeries. Scar tissue is less vascular than healthy subcutaneous fat, so absorption can be slower and less consistent. If you notice that doses injected near old scars seem less effective, talk to your prescriber about an alternative site rather than adjusting your dose independently.

Localised reactions, a small raised welt, brief itching, or mild redness, are normal and settle within hours. They become more likely when the needle is not inserted at the correct angle or when the same spot is reused too quickly, and our page on whether you can inject Wegovy wrong explains the most common technique mistakes and how to avoid them. If you are ever unsure about your technique, your prescriber or a community pharmacist can walk you through it. Our clinical team is also reachable via the contact page seven days a week.

When a wrong-site injection matters more: rotation, skin changes, and ongoing treatment

The real risk with injection site errors is cumulative rather than acute. A single off-target injection is rarely significant. A pattern of injecting in the same two-centimetre patch, week after week, is what leads to the kind of subcutaneous changes that interfere with Wegovy's effectiveness. The SmPC and Patient Information Leaflet are clear that you should rotate sites within each approved zone as well as between zones, so each individual point has roughly four weeks of recovery before it is used again.

Rotating deliberately also helps you notice early skin changes. Small lumps that do not resolve within a couple of weeks, skin that looks or feels thickened, or any unusual swelling at an injection site are worth mentioning to a clinician. These are not emergencies in most cases, but they are signals to change your routine.

A note that our prescribers flag regularly: people who are transferring from one GLP-1 medicine to another sometimes develop habits from the first pen that don't quite map onto the second. If you've been on a semaglutide injection for diabetes management before, for example, it's worth reading our guidance on how semaglutide injections can go wrong alongside the Wegovy-specific leaflet, as some technique details differ between pens. Specific dose and pen details are confirmed with your prescriber at the time of supply.

If something went wrong: what to do after an incorrect injection

If you believe your last injection missed the subcutaneous layer or went somewhere unintended, the first step is to stay calm. Do not inject a second dose. One of the questions our prescribers receive most often is whether a poorly absorbed injection justifies a catch-up dose; it does not. Taking two doses increases the risk of side effects significantly and the schedule is not designed to accommodate it. If you have already found yourself in this situation, our dedicated page on what to do if you injected Wegovy wrong sets out the recommended steps clearly. Follow the Patient Information Leaflet and, if uncertain, contact your prescribing team before the next scheduled dose.

If the site is unusually painful, red, hot to the touch, or showing signs of spreading inflammation after 24 hours, see a GP or attend an urgent care centre. These features can occasionally signal a skin infection and benefit from early assessment. Allergic reactions are rare but can present as widespread hives, swelling of the face, or breathing difficulty; these require emergency medical attention.

For anyone reassessing their injection confidence or considering whether this treatment is right for them, the full overview of Wegovy covers the broader clinical picture, and starting a free consultation connects you with one of our GPhC-registered prescribers who can review your circumstances on the same day. Every pen we dispatch arrives via tracked DPD next working day in plain, unbranded packaging, so the first thing you do at home is read that enclosed leaflet carefully.

Suspected side effects from any injection, including reactions at the injection site, can be reported directly to the MHRA through the Yellow Card scheme.